CS191289B2 - Method of producing 7-substituted 1,3-dialkyl-xanthines - Google Patents

Method of producing 7-substituted 1,3-dialkyl-xanthines

Info

Publication number
CS191289B2
CS191289B2 CS758669A CS866975A CS191289B2 CS 191289 B2 CS191289 B2 CS 191289B2 CS 758669 A CS758669 A CS 758669A CS 866975 A CS866975 A CS 866975A CS 191289 B2 CS191289 B2 CS 191289B2
Authority
CS
Czechoslovakia
Prior art keywords
xanthines
dialkyl
substituted
producing
Prior art date
Application number
CS758669A
Other languages
Czech (cs)
English (en)
Inventor
Wilhelm Konz
Richard Reichl
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CS191289B2 publication Critical patent/CS191289B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS758669A 1974-12-21 1975-12-18 Method of producing 7-substituted 1,3-dialkyl-xanthines CS191289B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (1)

Publication Number Publication Date
CS191289B2 true CS191289B2 (en) 1979-06-29

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
CS758669A CS191289B2 (en) 1974-12-21 1975-12-18 Method of producing 7-substituted 1,3-dialkyl-xanthines

Country Status (31)

Country Link
US (1) US3998953A (sv)
JP (1) JPS5188995A (sv)
AT (1) AT341540B (sv)
AU (1) AU501889B2 (sv)
BE (1) BE836898A (sv)
BG (1) BG25518A3 (sv)
CA (1) CA1036159A (sv)
CH (1) CH628346A5 (sv)
CS (1) CS191289B2 (sv)
DD (1) DD124984A5 (sv)
DE (1) DE2460929A1 (sv)
DK (1) DK137677C (sv)
ES (2) ES443738A1 (sv)
FI (1) FI62089C (sv)
FR (1) FR2294706A1 (sv)
GB (1) GB1517710A (sv)
GR (1) GR59204B (sv)
HU (1) HU174673B (sv)
IE (1) IE43208B1 (sv)
IL (1) IL48697A (sv)
LU (1) LU73972A1 (sv)
NL (1) NL7514837A (sv)
NO (1) NO144928C (sv)
NZ (1) NZ179599A (sv)
PH (1) PH11810A (sv)
PL (1) PL99165B1 (sv)
RO (1) RO68381A (sv)
SE (1) SE420493B (sv)
SU (1) SU603340A3 (sv)
YU (1) YU39004B (sv)
ZA (1) ZA757865B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (en) * 1997-12-17 1999-06-24 University Of South Florida Adenosine receptor antagonists with improved bioactivity
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (sv) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (sv) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
NO144928B (no) 1981-08-31
FI62089B (fi) 1982-07-30
FI62089C (fi) 1982-11-10
JPS5188995A (sv) 1976-08-04
IE43208B1 (en) 1981-01-14
ATA904575A (de) 1977-06-15
IL48697A0 (en) 1976-02-29
NO754317L (sv) 1976-06-22
RO68381A (ro) 1982-02-26
YU39004B (en) 1983-12-31
NZ179599A (en) 1978-03-06
YU323475A (en) 1982-08-31
DK137677C (da) 1978-09-25
ZA757865B (en) 1977-08-31
FI753543A (sv) 1976-06-22
FR2294706B1 (sv) 1978-12-01
NO144928C (no) 1981-12-09
FR2294706A1 (fr) 1976-07-16
AU8754775A (en) 1977-06-23
SU603340A3 (ru) 1978-04-15
GR59204B (en) 1977-11-26
CA1036159A (en) 1978-08-08
IE43208L (en) 1976-06-21
GB1517710A (en) 1978-07-12
PH11810A (en) 1978-07-10
IL48697A (en) 1979-07-25
ES443738A1 (es) 1977-04-16
BG25518A3 (en) 1978-10-10
NL7514837A (nl) 1976-06-23
DK137677B (da) 1978-04-17
DD124984A5 (sv) 1977-03-23
BE836898A (fr) 1976-06-21
HU174673B (hu) 1980-03-28
AU501889B2 (en) 1979-07-05
US3998953A (en) 1976-12-21
CH628346A5 (de) 1982-02-26
DK571875A (da) 1976-06-22
PL99165B1 (pl) 1978-06-30
SE420493B (sv) 1981-10-12
DE2460929C2 (sv) 1987-12-17
LU73972A1 (sv) 1977-02-15
ES451457A1 (es) 1977-10-01
AT341540B (de) 1978-02-10
DE2460929A1 (de) 1976-06-24
SE7514477L (sv) 1976-06-22

Similar Documents

Publication Publication Date Title
JPS53101385A (en) Method of producing phenyllpyrimidine
CS188985B2 (en) Method of producing aryl-1-azolylmethanes
CS189717B2 (en) Method of producing novel 5,9-beta-disubstituted 2-tetrahydrofurfuryl-6,7-benzomorphanes
CS191960B2 (en) Method of producing novel 2-decarboxy-2-/5-tatrazolyl/-11-deoxy-omega-pentanorprostaglandins
CS188221B2 (en) Method of producing new 2-tetrahydrofurfuryl-6,7-benzomorphanes
ZA75496B (en) Method of producing 1-n-<l-(-)-alpha-hydroxy-epsilon-aminobutyryl> xk-62-2
CS188235B2 (en) Method of producing new derivatives ryfamicine
CS187318B2 (en) Method of producing acylureidocephalosporin compounds
CS191264B2 (en) Method of producing new pyridobenzodiazepinones
CS188938B2 (en) Method of producing xanthene-9-spiro-4-piperidines
CS191289B2 (en) Method of producing 7-substituted 1,3-dialkyl-xanthines
SU677666A3 (en) Method of producing 7l-or extradiols
CS189635B2 (en) Method of producing bromderivatives of 4-imido-thioazetidin-2-one
CS183785B2 (en) Method of producing s-triazolo-3,4-benzothiazoles
CS182298B2 (en) Method of producing substituted benzendisulphon-amides
CS182292B2 (en) Method of producing melone
CS189777B2 (en) Method of producing 2 alpha, 3 alpha, 16 alpha, 17 alpha-diepoxy-17 beta-brom-5 alpha-androstene
CS194733B2 (en) Method of producing novel 11-deoxy-omega-pentanorprostaglandins
CS190503B2 (en) Method of producing novel derivatives of 5,7-dihydroxy tetrahydreisequinoline
IL46268A0 (en) Method of producing rifamycins
CS181287B2 (en) Method of producing n,n-diallyldichloroacetamide
CS183848B2 (en) Method of producing 3,3a,6,6a-tetrahydrofuro/3,4-b/-furan-2,4-diones
CS188945B2 (en) Method of producing 1-aryluracils
CS190494B2 (en) Method of producing pgf beta-prostaglandins
CS185674B2 (en) Method of producing 1-phenyl-4-amino-5-chlor-6-pyridazone